Two small IPOs and two SPACs debuted this past week. Seven IPOs and three SPACs submitted initial filings. Hong Kong-based ICT solutions provider Global Engine Group (GLE) priced its downsized IPO at the bottom of the range to raise $8...read more
Kairos Pharma, a Phase 2 biotech developing therapies for cancer, raised $6 million by offering 1.55 million shares at $4.00. The company priced the offering on Monday morning; the stock finished the day at $2.60, a decline of 35%. The Los Angeles, CA-based...read more
Kairos Pharma, a Phase 2 biotech developing therapies for cancer, announced terms for its IPO on Wednesday. The Los Angeles, CA-based company plans to raise $6 million by offering 1.6 million shares at $4. At the proposed price, Kairos Pharma would command a...read more
The third quarter wrapped up with four IPOs and eight pipeline additions. Oncology biotech Adlai Nortye (ANL) raised $58 million at an $849 million market cap. The company originally planned to raise $72 million in August but never priced; it...read more
US IPO Weekly Recap: 2 microcaps list as pipeline gets a big boost
Two small IPOs and two SPACs debuted this past week. Seven IPOs and three SPACs submitted initial filings. Hong Kong-based ICT solutions provider Global Engine Group (GLE) priced its downsized IPO at the bottom of the range to raise $8...read more
Micro-cap cancer biotech Kairos Pharma prices IPO at $4
Kairos Pharma, a Phase 2 biotech developing therapies for cancer, raised $6 million by offering 1.55 million shares at $4.00. The company priced the offering on Monday morning; the stock finished the day at $2.60, a decline of 35%. The Los Angeles, CA-based...read more
Cancer biotech Kairos Pharma sets terms for $6 million IPO
Kairos Pharma, a Phase 2 biotech developing therapies for cancer, announced terms for its IPO on Wednesday. The Los Angeles, CA-based company plans to raise $6 million by offering 1.6 million shares at $4. At the proposed price, Kairos Pharma would command a...read more
US IPO Weekly Recap: Holdover Adlai Nortye leads 4 IPO week as more small deals enter the pipeline
The third quarter wrapped up with four IPOs and eight pipeline additions. Oncology biotech Adlai Nortye (ANL) raised $58 million at an $849 million market cap. The company originally planned to raise $72 million in August but never priced; it...read more